Drug Shortage Report for OXYTOCIN INJECTION, USP
| Report ID | 175199 |
| Drug Identification Number | 02139561 |
| Brand name | OXYTOCIN INJECTION, USP |
| Common or Proper name | OXYTOCIN INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | OXYTOCIN |
| Strength(s) | 10UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 mL |
| ATC code | H01BB |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-11-17 |
| Estimated end date | Unknown |
| Actual end date | 2023-03-01 |
| Shortage status | Resolved |
| Updated date | 2023-04-05 |
| Company comments | Fresenius Kabi Canada regrets to advise that our Oxytocin Injection, USP Synthetic 10 USP units/mL MD Vial 10 mL is on allocation effective immediately. Contract customers are allocated 100% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-04-05 | French | Compare |
| v4 | 2023-04-05 | English | Compare |
| v3 | 2022-11-18 | English | Compare |
| v2 | 2022-11-17 | French | Compare |
| v1 | 2022-11-17 | English | Compare |
Showing 1 to 5 of 5